- Entry
- $4.70
- Final
- $3.21 -31.7%
- Target
- —
- Score
- -1.00
Today, Sana biotechnology ($SANA) announced a historic milestone. The insulin producing islets they engineered to survive in humans without potentially fatal immunosuppression drugs have now been observed to avoid rejection for 1 year and still produce insulin. A type 1 diabetes cure is on the horizon and $SANA seems to be on pace to be first to market by several years. They presented at the JP Morgan 2026 healthcare conference. You can view their presentation here: [https://ir.sana.com/node/9796/html](https://ir.sana.com/node/9796/html) Picture of the …
— ORIGINAL POST ·
$SANA reports 1 year survival of transplanted insulin producing islets without immunosuppression
· r/wallstreetbets
· Jan 14, 2026